Antibody-drug conjugates in oncology: insights into Current challenges

Expert Opin Biol Ther. 2023 Jul-Dec;23(11):1035-1038. doi: 10.1080/14712598.2023.2276288. Epub 2023 Dec 15.

Authors

Ahmad Z Al Meslamani^{1

2}, Mohammad F Bostanudin^{1

2}

Affiliations

¹ College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates.
² AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates.

PMID: 37883244
DOI: 10.1080/14712598.2023.2276288

No abstract available

Keywords: ADCs; Cancer therapy; Challenges; Resistance; heterogeneity; toxicity.

Publication types

Editorial

MeSH terms

Antibodies, Monoclonal
Antineoplastic Agents* / therapeutic use
Humans
Immunoconjugates* / therapeutic use

Substances

Immunoconjugates
Antineoplastic Agents
Antibodies, Monoclonal